RUBEX |
VALRUBICIN IMPURITY, DOXORUBICIN |
NSC-123127 |
ADRIAMYCIN |
DOXIL |
HYDROXYDAUNORUBICIN |
ADRIBLASTINA |
DOXORUBICIN |
(1S,3S)-3-GLYCOLOYL-3,5,12-TRIHYDROXY-10-METHOXY-6,11-DIOXO-1,2,3,4,6,11-HEXAHYDROTETRACEN-1-YL 3-AMINO-2,3,6-TRIDEOXY-ALPHA-L-LYXO-HEXOPYRANOSIDE |
DOXORUBICIN HYDROCHLORIDE |
(8S-CIS)-10-((3-AMINO-2,3,6-TRIDEOXY-ALPHA-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-5,12-NAPHTHACENEDIONE |
ADRIAMYCIN® |
14-HYDROXYDAUNORUBICINE |
DOXIL® |
DOXORUBICINE |
14-HYDROXYDAUNOMYCIN |
DOXORUBICINUM |
drugbank:00997 |
pubchem.compound:31703 |
chemidplus:23214-92-8 |
rxcui:3639 |
chembl:CHEMBL53463 |
Year of Approval | 1974 |
Drug Class | antineoplastic agents |
FDA Approval | approved |
Drug Class | Small Molecule |
Drug Indications | antineoplastic agent |
Drug Categories | cytotoxic antibiotics and related substances |
Drug Categories | anthracycline topoisomerase inhibitor |
Drug Categories | bsep/abcb11 substrates |
Drug Categories | bsep/abcb11 substrates with narrow therapeutic index |
Drug Categories | cardiotoxic antineoplastic agents |
Drug Categories | cytochrome p-450 cyp2b6 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp2d6 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp3a substrates |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors |
Drug Categories | cytochrome p-450 cyp3a4 inhibitors (strength unknown) |
Drug Categories | cytochrome p-450 cyp3a4 substrates with a narrow therapeutic index |
Drug Categories | cytochrome p-450 enzyme inhibitors |
Drug Categories | cytochrome p-450 substrates |
Drug Categories | drugs causing inadvertant photosensitivity |
Drug Categories | p-glycoprotein inducers |
Drug Categories | p-glycoprotein inhibitors |
Drug Categories | p-glycoprotein substrates |
Drug Categories | p-glycoprotein substrates with narrow therapeutic index |
Drug Categories | photosensitizing agents |
inhibitor (inhibitory) |
Trial Name | AEZS-108, AN-152 |
Novel drug target | Established target |
Trial Name | MTC-DOX, MTC-doxorubicin |
n/a |
n/a |
Evidence Type | Actionable |
Approval Status | Guideline |
Response Type | sensitive |
DOXORUBICIN | DrugBank Drug Name |
23214-92-8 | CAS Number |
Adriablastina | Drug Brand |
Drug Type | small molecule |
Drug Groups | approved |
Drug Groups | investigational |
DOXORUBICIN | Primary Drug Name |
Drug Class | antineoplastic agents |
Year of Approval | 1974 |
Drug Indications | antineoplastic agent |
Drug Class | Small Molecule |
FDA Approval | approved |
CHEMBL53463 | ChEMBL Drug ID |
C456 | NCI drug code |
D07VLY | TTD Drug ID |
DOXORUBICIN | GuideToPharmacology Ligand Name |